ADVERTISEMENT
Biden cap on drug costs will save US seniors over $1,000 a year, study finds
The cap, introduced as part of President Joe Biden's Inflation Reduction Act, applies to the Medicare program for people age 65 or over and those with disabilities.
U.S. President Joe Biden delivers remarks during an event on Medicare drug price negotiations, in Prince George's County, Maryland, U.S., Aug.15, 2024. / Reuters/Ken Cedeno
WASHINGTON (Reuters) -More than 1 million people in the U.S. will save over $1,000 a year beginning in 2025, when an annual $2,000 cap on prescription drug out-of-pocket costs kicks in, the leading lobbying group for older Americans said on Aug.28.
The cap, introduced as part of President Joe Biden's Inflation Reduction Act, applies to the Medicare program for people age 65 or over and those with disabilities. Its prescription drug component, known as Part D, provides coverage for around 56 million people.
AARP, which lobbied in favor of the law, commissioned health consultancy Avalere to conduct a study on the new benefit and published a report on the findings on Aug.27.
The $2,000 cap will lower prices in 2025 for more than 3.2 million people, or around 8.4 percent of Part D beneficiaries who do not receive other subsidies, AARP said in its report.
That represents a stark change from how Medicare Part D previously worked. Before the Inflation Reduction Act, beneficiaries who did not qualify for low income subsidies were required to pay 5 percent of drug costs regardless of how much they had already paid.
The cap is expected to provide long-term savings, particularly for those most in need, even if Part D premiums rise next year as expected, Leigh Purvis, an AARP prescription drug pricing expert, said during a press briefing.
By 2029, the lowered cap will help 4.1 million people, or around 9.6 percent of beneficiaries, AARP said.
The biggest impact will be felt by those who use high-priced, branded drugs the most.
Diana DiVito, 82, said the cost of the treatment she takes for chronic leukemia has averaged $858 per month over more than five years.
Her co-insurance was 33 percent of the drug's cost until she reached the Part D cap of several thousand dollars. After that, she still had to pay 5 percent of the drug's cost, DiVito said. In 2024, the law eliminated that additional payment.
"When I saw the first co-pay I almost had a heart attack," DiVito, an AARP member, said during the briefing. "It's a tremendous weight off my shoulders and I'm incredibly grateful."
Almost 40 percent of people who reach the cap between 2025 and 2029, some 1.4 million, will save more than $1,000 a year, including 420,000 people, or around 12 percent, who will save more than $3,000 annually. Currently, some patients pay over $10,000 a year, AARP said in its report.
The study excluded Part D beneficiaries who receive low income subsidies and pay nominal amounts for drugs from its analysis.
"The money seniors will no longer have to spend out-of-pocket is money they can invest in their families, broader health needs or simply save to achieve greater financial stability," AARP CEO Jo Ann Jenkins said.
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login